Hikma Pharmaceuticals PLC HIK.L Stock
Hikma Pharmaceuticals PLC Price Chart
Hikma Pharmaceuticals PLC HIK.L Financial and Trading Overview
| Hikma Pharmaceuticals PLC stock price | 1978 GBP |
| Previous Close | 1900 GBP |
| Open | 0 GBP |
| Bid | 0 GBP x 0 |
| Ask | 0 GBP x 0 |
| Day's Range | 0 - 0 GBP |
| 52 Week Range | 0 - 1915.5 GBP |
| Volume | 3.98K GBP |
| Avg. Volume | 557.17K GBP |
| Market Cap | 4.25B GBP |
| Beta (5Y Monthly) | 0.390038 |
| PE Ratio (TTM) | 29.166666 |
| EPS (TTM) | 0.67 GBP |
| Forward Dividend & Yield | 0.46 (2.39%) |
| Ex-Dividend Date | March 23, 2023 |
| 1y Target Est | 20.66 GBP |
HIK.L Valuation Measures
| Enterprise Value | 5.19B GBP |
| Trailing P/E | 29.166666 |
| Forward P/E | 11.882716 |
| PEG Ratio (5 yr expected) | 2.7 |
| Price/Sales (ttm) | 1.6901149 |
| Price/Book (mrq) | 198.57643 |
| Enterprise Value/Revenue | 2.061 |
| Enterprise Value/EBITDA | 6.8 |
Trading Information
Hikma Pharmaceuticals PLC Stock Price History
| Beta (5Y Monthly) | 0.390038 |
| 52-Week Change | 26.96% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1915.5 GBP |
| 52 Week Low | 0 GBP |
| 50-Day Moving Average | 1815.87 GBP |
| 200-Day Moving Average | 1588.59 GBP |
HIK.L Share Statistics
| Avg. Volume (3 month) | 557.17K GBP |
| Avg. Daily Volume (10-Days) | 586.19K GBP |
| Shares Outstanding | 220.7M |
| Float | 154.03M |
| Short Ratio | N/A |
| % Held by Insiders | 31.01% |
| % Held by Institutions | 37.65% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.56 |
| Trailing Annual Dividend Yield | 0.029% |
| 5 Year Average Dividend Yield | 184.00% |
| Payout Ratio | 0.6316 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 7.46% |
| Operating Margin (ttm) | 23.48% |
| Gross Margin | 50.25% |
| EBITDA Margin | 30.31% |
Management Effectiveness
| Return on Assets (ttm) | 8.35% |
| Return on Equity (ttm) | 8.27% |
Income Statement
| Revenue (ttm) | 2.52B GBP |
| Revenue Per Share (ttm) | 11.24 GBP |
| Quarterly Revenue Growth (yoy) | -2.50% |
| Gross Profit (ttm) | 1.27B GBP |
| EBITDA | 763M GBP |
| Net Income Avi to Common (ttm) | 188M GBP |
| Diluted EPS (ttm) | 0.66 |
| Quarterly Earnings Growth (yoy) | -91.29% |
Balance Sheet
| Total Cash (mrq) | 292M GBP |
| Total Cash Per Share (mrq) | 1.33 GBP |
| Total Debt (mrq) | 1.28B GBP |
| Total Debt/Equity (mrq) | 59.73 GBP |
| Current Ratio (mrq) | 1.856 |
| Book Value Per Share (mrq) | 9.694 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 530M GBP |
| Levered Free Cash Flow (ttm) | 299.5M GBP |
Profile of Hikma Pharmaceuticals PLC
| Country | United Kingdom |
| State | N/A |
| City | London |
| Address | 1 New Burlington Place |
| ZIP | W1S 2HR |
| Phone | 44 20 7399 2760 |
| Website | https://www.hikma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 8800 |
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company was founded in 1978 and is headquartered in London, the United Kingdom.
Q&A For Hikma Pharmaceuticals PLC Stock
What is a current HIK.L stock price?
Hikma Pharmaceuticals PLC HIK.L stock price today per share is 1978 GBP.
How to purchase Hikma Pharmaceuticals PLC stock?
You can buy HIK.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hikma Pharmaceuticals PLC?
The stock symbol or ticker of Hikma Pharmaceuticals PLC is HIK.L.
Which industry does the Hikma Pharmaceuticals PLC company belong to?
The Hikma Pharmaceuticals PLC industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hikma Pharmaceuticals PLC have in circulation?
The max supply of Hikma Pharmaceuticals PLC shares is 2.22M.
What is Hikma Pharmaceuticals PLC Price to Earnings Ratio (PE Ratio)?
Hikma Pharmaceuticals PLC PE Ratio is 29.52238800 now.
What was Hikma Pharmaceuticals PLC earnings per share over the trailing 12 months (TTM)?
Hikma Pharmaceuticals PLC EPS is 0.67 GBP over the trailing 12 months.
Which sector does the Hikma Pharmaceuticals PLC company belong to?
The Hikma Pharmaceuticals PLC sector is Healthcare.
Hikma Pharmaceuticals PLC HIK.L included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| UK FTSE All Share FTAS | 4584.23 GBP 5862.94 USD |
-0.23
|
— — | 4573.89 GBP 5849.71 USD | 4595.42 GBP 5877.25 USD | — - | — — |
| ISE Mini FTSE 100 Index UKX | — — |
0
|
— — | — — | — — | — - | — — |
| NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
| FTSE 350 FTLC | 4631.57 GBP 5923.48 USD |
-0.24
|
— — | 4621.09 GBP 5910.08 USD | 4643.4 GBP 5938.61 USD | — - | — — |
| NASDAQ AlphaDEX United Kingdom NQDXGBN | 1306.57 USD — |
+0.09
|
— — | 1296.75 USD — | 1308.77 USD — | — - | — — |
| FTSE 100 FTSE | 8420.26 GBP 10768.97 USD |
-0.22
|
— — | 8401.4 GBP 10744.85 USD | 8441.68 GBP 10796.37 USD | — - | — — |
- {{ link.label }} {{link}}